ASIA PACIFIC OPIOIDS DRUG MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • ASIA PACIFIC OPIOIDS DRUG MARKET FORECAST 2019-2027

ASIA PACIFIC OPIOIDS DRUG MARKET FORECAST 2019-2027

The regional market for opioid drugs in the Asia-Pacific is the fastest growing one mainly due to growing surgical procedures and the subsequent investments from local, regional players for elucidating abuse-deterrent opioids drug medications. The regional growth has been quantified to be 3.06% during the forecast period 2019-2027. The economies of China, India, Japan, Australia, South Korea and Rest of Asia Pacific are majorly studied in this report to quantify the market trends for opioid drugs.

ASIA PACIFIC OPIOIDS DRUG MARKET FORECAST 2019-2027

Asia Pacific Opioids Drug Market by Products (Buprenorphine, Fentanyl, Hydrocodone, Morphine, Oxycodone, Tramadol and Other Products), by Application (Pain Relief), & by Geography.

Request free sample

The regional market for opioid drugs in the Asia-Pacific is the fastest growing one mainly due to growing surgical procedures and the subsequent investments from local, regional players for elucidating abuse-deterrent opioids drug medications. The regional growth has been quantified to be 3.06% during the forecast period 2019-2027. The economies of China, India, Japan, Australia, South Korea and Rest of Asia Pacific are majorly studied in this report to quantify the market trends for opioid drugs.

Although opioid drugs have massive importance in pain management for many forms of stress, there are associated many side effects and addictions that have called for attention from the public to demand limitations on its prescription. The Asia Pacific is seeing an increase in the rate of opioid dependence patients in a few densely populated countries. So, severe regulations undertaken by some governments are in active status to restrict the overdose and misuse of opioid in those countries. Australia has the fastest growing market for opioid drugs since they have invested and promoted opioid pharmacotherapy treatments which replace the opioid drug with a legally obtained, longer lasting variant of opioid. These promotions have yielded very good results in the country.

Hikma Pharmaceuticals PLC, Acura Pharmaceuticals, Inc., Lannett Co. Inc., BioDelivery Sciences International, Inc., Cipher Pharmaceuticals, Inc., Collegium Pharmaceutical, Inc., Daiichi Sankyo, Inc., Allergan PLC, Egalet Corp., Indivior, Inc., Insys Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Lupin Ltd., Mylan NV, Pfizer, Inc., Purdue Pharma LP, Sanofi-Aventis S.A., Sun Pharmaceutical Industries Limited (Sun Pharma) and Teva Pharmaceutical Industries Ltd. are the predominant market players for opioid drugs in the Asia-Pacific region.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • OXYCODONE HOLDS THE LARGEST MARKET SHARE IN TERMS OF PRODUCT
      • ANESTHESIA IS THE MAJORLY USED APPLICATION
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • INCREASING ROAD ACCIDENTS AND SURGICAL PROCEDURES
      • ESCALATING PALLIATIVE CARE FOR PATIENTS SUFFERING INTENSELY
      • USAGE OF ABUSE DETERRENT FORMULATIONS TO RESTRICT THE OPIOID ABUSE
      • GROWING OCCURRENCE OF CHRONIC PAIN
    • MARKET RESTRAINTS
      • MISUSE OF OPIOIDS
      • STRINGENT REGULATORY FRAMEWORK
    • MARKET OPPORTUNITIES
      • INCREASING USE OF EXTENDED-RELEASE OPIOID FORMULATIONS
      • WIDE RANGE OF APPLICATIONS OF OPIOIDS IN THE THERAPEUTIC MANAGEMENT
    • MARKET CHALLENGES
      • INCREASING NUMBER OF LAWSUITS AGAINST OPIOIDS MANUFACTURERS
      • RISING OCCURRENCE OF DEATHS RELATED TO OPIOID OVERDOSE
  1. MARKET BY PRODUCTS
    • BUPRENORPHINE
    • FENTANYL
    • HYDROCODONE
    • MORPHINE
    • OXYCODONE
    • TRAMADOL
    • OTHER PRODUCTS
  2. MARKET BY APPLICATION
    • PAIN RELIEF
      • CANCER PAIN
      • POSTOPERATIVE PAIN MANAGEMENT
      • LOW BACK PAIN
      • ORTHOPEDIC
      • NEUROPATHIC
      • FIBROMYALGIA
    • ANESTHESIA
    • COUGH SUPPRESSION
    • DIARRHEA SUPPRESSION
    • DEADDICTION
  3. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF COMPETITIVE RIVALRY
    • PIPELINE ANALYSIS
    • INDUSTRY EVENTS IN OPIOID DRUGS MARKET
    • TECHNOLOGIES ADVANCEMENT
    • OPPORTUNITY MATRIX
  4. GEOGRAPHICAL ANALYSIS
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
  1. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • ACURA PHARMACEUTICALS, INC.
      • ALLERGAN PLC
      • BIODELIVERY SCIENCES INTERNATIONAL, INC.
      • CIPHER PHARMACEUTICALS INC.
      • COLLEGIUM PHARMACEUTICAL, INC.
      • DAIICHI SANKYO, INC.
      • EGALET CORP.
      • HIKMA PHARMACEUTICALS PLC
      • INDIVIOR INC.
      • INSYS THERAPEUTICS, INC.
      • JANSSEN PHARMACEUTICALS, INC.
      • JOHNSON & JOHNSON
      • LANNETT CO. INC.
      • LUPIN LTD.
      • MYLAN NV
      • PFIZER INC.
      • PURDUE PHARMA LP
      • SANOFI-AVENTIS S.A.
      • SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
      • TEVA PHARMACEUTICAL INDUSTRIES LTD.

 

TABLE LIST

TABLE 1       ASIA PACIFIC OPIOIDS DRUG MARKET 2019-2027 ($ MILLION)

TABLE 2       ANESTHETIC EFFECTS OF DRUGS AT DIFFERENT OPIOID RECEPTORS

TABLE 3       NUMBER OF LAWSUITS SETTLED BY OPIOIDS MANUFACTURING COMPANIES AND PHARMACIES 2015–2027

TABLE 4       ASIA PACIFIC OPIOIDS DRUGS MARKET BY PRODUCTS 2019-2027 ($ MILLION)

TABLE 5       ASIA PACIFIC BUPRENORPHINE MARKET 2019-2027 ($ MILLION)

TABLE 6       ASIA PACIFIC FENTANYL MARKET 2019-2027 ($ MILLION)

TABLE 7       ASIA PACIFIC HYDROCODONE MARKET 2019-2027 ($ MILLION)

TABLE 8       ASIA PACIFIC MORPHINE MARKET 2019-2027 ($ MILLION)

TABLE 9       ASIA PACIFIC OXYCODONE MARKET 2019-2027 ($ MILLION)

TABLE 10     ASIA PACIFIC TRAMADOL MARKET 2019-2027 ($ MILLION)

TABLE 11     ASIA PACIFIC OTHER PRODUCTS MARKET 2019-2027 ($ MILLION)

TABLE 12     ASIA PACIFIC OPIOIDS DRUGS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 13     ASIA PACIFIC OPIOIDS DRUGS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 14     ASIA PACIFIC PAIN RELIEF MARKET 2019-2027 ($ MILLION)

TABLE 15     ASIA PACIFIC PAIN RELIEF MARKET BY TYPES 2019-2027 ($ MILLION)

TABLE 16     ASIA PACIFIC CANCER PAIN MARKET 2019-2027 ($ MILLION)

TABLE 17     ASIA PACIFIC POSTOPERATIVE PAIN MANAGEMENT MARKET 2019-2027 ($ MILLION)

TABLE 18     ASIA PACIFIC LOW BACK PAIN MARKET 2019-2027 ($ MILLION)

TABLE 19     ASIA PACIFIC ORTHOPEDIC MARKET 2019-2027 ($ MILLION)

TABLE 20     ASIA PACIFIC NEUROPATHIC MARKET 2019-2027 ($ MILLION)

TABLE 21     ASIA PACIFIC FIBROMYALGIA MARKET 2019-2027 ($ MILLION)

TABLE 22     ASIA PACIFIC ANESTHESIA MARKET 2019-2027 ($ MILLION)

TABLE 23     ASIA PACIFIC COUGH SUPPRESSION MARKET 2019-2027 ($ MILLION)

TABLE 24     ASIA PACIFIC DIARRHEA SUPPRESSION MARKET 2019-2027 ($ MILLION)

TABLE 25     ASIA PACIFIC DEADDICTION MARKET 2019-2027 ($ MILLION)

TABLE 26     PIPELINE ANALYSES OF OPIOID DRUGS

TABLE 27     ASIA PACIFIC GERD DRUGS AND DEVICES MARKET BY COUNTRY 2019-2027 ($ MILLION)

 

FIGURE LIST

FIGURE 1     ASIA PACIFIC OPIOIDS DRUG MARKET 2019-2027 ($ MILLION)

FIGURE 2     ASIA PACIFIC OPIOIDS DRUGS MARKET SHARE BY PRODUCTS 2018 & 2027 (%)

FIGURE 3     ASIA PACIFIC OPIOIDS DRUGS MARKET SHARE BY APPLICATION 2018 & 2027 (%)

FIGURE 4     PORTER’S FIVE FORCE MODEL

FIGURE 5     ASIA PACIFIC OPIOIDS DRUGS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 6     JAPAN GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 7     CHINA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 8     INDIA GERD DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)

FIGURE 9     AUSTRALIA OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 10   SOUTH KOREA OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 11   REST OF ASIA PACIFIC OPIOIDS DRUGS MARKET 2019-2027 ($ MILLION)

FIGURE 12   OPIOIDS MARKET POSITION ANALYSIS 2017

  1. GEOGRAPHICAL ANALYSIS
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA PACIFIC
  1. MARKET BY PRODUCTS
    • BUPRENORPHINE
    • FENTANYL
    • HYDROCODONE
    • MORPHINE
    • OXYCODONE
    • TRAMADOL
    • OTHER PRODUCTS
  2. MARKET BY APPLICATION
    • PAIN RELIEF
      • CANCER PAIN
      • POSTOPERATIVE PAIN MANAGEMENT
      • LOW BACK PAIN
      • ORTHOPEDIC
      • NEUROPATHIC
      • FIBROMYALGIA
    • ANESTHESIA
    • COUGH SUPPRESSION
    • DIARRHEA SUPPRESSION
    • DEADDICTION

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now